Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Marie Skłodowska-Curie Action · Running

IMACS Accessible imaging : shaping the future of imaging

Coordinator
Universite D'aix Marseille, France
Runs
1 June 2026 to 31 May 2031
Status
Running
EU funding
€2.9m
Total cost
—
Partners
47 organisations in 13 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101261856

What the project is doing

In the project's own words, from its summary on CORDIS.

Biomedical imaging is crucial for advances in life sciences and in medicine, particularly for diagnosing and monitoring major diseases. Challenges hinder a widespread use of imaging tools, such as the lack of accessible equipment, efficient examinations, geographical inequalities, and the exclusion of certain population groups. Ensuring imaging capabilities to reach underserved populations and territories is essential.

This is not just a matter of technology, but one of equity and global health impact. The IMACS program is designed to address these challenges, over 54-months, by training a new generation of researchers specialised in biomedical imaging and offering them an excellent research environment within Aix Marseille University (AMU), the University of Tubingen (UT) and a network of 80 academic and 61 non-academic partners including 5 hospitals.

The program seeks to recruit 17 experienced researchers (ERs) for 36-month bottom-up projects through a transparent and merit-based selection process. It focuses on three dimensions: 1. Interdisciplinary and international training: To train researchers capable of working in interdisciplinary and international environments, combining research and innovation across all imaging modalities, with international secondments. 2.

Socio-economic integration: To prepare researchers for academic challenges in imaging and integrate them into medical technology development and health sectors in biomedical imaging while facilitating their intersectoral immersion. 3. Promotion of innovation: To encourage ambitious projects that enhance accessible imaging technologies (hardware and digital tools), aiming at equal healthcare access while strengthening Europe’s competitiveness in medical technology.

Overall, IMACS Programme is a key element in the broader transformation strategy of postgraduate training at AMU and UT, aligning with regional, national, and European priorities.

Who is involved

OrganisationCityCountryRole
Universite D'aix MarseilleMarseilleFranceCoordinator
The University of QueenslandBrisbaneAustraliaAssociatedpartner
University of British ColumbiaVancouverCanadaAssociatedpartner
Centre Hospitalier Universitaire VaudoisLausanneSwitzerlandAssociatedpartner
Universite De GeneveGeneveSwitzerlandAssociatedpartner
European Molecular Biology LaboratoryHeidelbergGermanyAssociatedpartner
Friedrich-Alexander-Universitaet Erlangen-NuernbergErlangenGermanyAssociatedpartner
Friedrich-Schiller-Universität JenaJenaGermanyAssociatedpartner
Karlsruher Institut Fuer TechnologieKarlsruheGermanyAssociatedpartner
Leibniz-Institut Fuer Photonische Technologien E.v.JenaGermanyAssociatedpartner
Martin-Luther-Universitat Halle-WittenbergHalleGermanyAssociatedpartner
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eVMunchenGermanyAssociatedpartner
Nvision Quantum Technologies GmbHUlmGermanyAssociatedpartner
SI Stuttgart Instruments GmbHStuttgartGermanyAssociatedpartner
Siemens Healthineers AGForchheimGermanyAssociatedpartner
Vicinity Bio GmbHTübingenGermanyAssociatedpartner
Universidad Autonoma De MadridMadridSpainAssociatedpartner
Ita-Suomen YliopistoKuopioFinlandAssociatedpartner
A5 ScienceAix En ProvenceFranceAssociatedpartner
Advanced Accelerator Applications Molecular Imaging France S.A.SSaint-Genis-PouillyFranceAssociatedpartner
Centre Hospitalier Regional De Marseille Assistance Publique-Hopitaux MarseilleMarseille Cedex 20FranceAssociatedpartner
DeepcolorNantesFranceAssociatedpartner
Fondation Universitaire AMIDEXMarseilleFranceAssociatedpartner
Ge Medical Systems ScsBucFranceAssociatedpartner
Institut National De La Sante Et De La Recherche MedicaleParisFranceAssociatedpartner
Kaer Labs SASNantesFranceAssociatedpartner
Lightcore TechnologiesMarseilleFranceAssociatedpartner
Multiwave TechnologiesMarseilleFranceAssociatedpartner
Olea MedicalLa CiotatFranceAssociatedpartner
Orano SupportChatillonFranceAssociatedpartner
Siemens Healthcare SASCourbevoieFranceAssociatedpartner
Silon TherapeuticsMarseilleFranceAssociatedpartner
SolnilMarseilleFranceAssociatedpartner
Istituto Romagnolo per Lo Studio Dei Tumori Dino Amadori - Irst SRLMeldolaItalyAssociatedpartner
Politecnico Di MilanoMilanoItalyAssociatedpartner
Technische Universiteit DelftDelftNetherlandsAssociatedpartner
Raphael Samuel Matthew KaplanTrondheimNorwayAssociatedpartner
Imperial College of Science Technology and MedicineLondonUnited KingdomAssociatedpartner
King's College LondonLondonUnited KingdomAssociatedpartner
The University of BirminghamBirminghamUnited KingdomAssociatedpartner
Florida International UniversityMiamiUnited StatesAssociatedpartner
Memorial Sloan Kettering Cancer CenterNew York CityUnited StatesAssociatedpartner
The Regents of the University of CaliforniaOaklandUnited StatesAssociatedpartner
The Trustees of the University of Pennsylvania CorpPhiladelphiaUnited StatesAssociatedpartner
Trustees of Purdue UniversityWest LafayetteUnited StatesAssociatedpartner
Trustees of Boston UniversityBostonUnited StatesAssociatedpartner
Truong Dai Hoc Khoa Hoc Va Cong Nghe Ha NoiHanoiVNAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI